Next generation sequencing panel for non-invasive prenatal testing (NIPT) and newborn screening (NBS). Provides precision genetic profiling for maternal and pediatric healthcare applications.
Manufactured by
Genes 2Me Private Ltd
Gurugram, Haryana, India
Manufactures molecular diagnostic solutions including next-generation sequencing panels for oncology and clinical genomics, real-time PCR testing kits, and point-of-care molecular diagnostic systems. Specializes in precision NGS panels, validated RT-PCR assays for disease detection including cancer biomarkers and infectious diseases, and nucleic acid extraction kits. Products serve applications in oncology, maternal and child care, infectious disease testing, and personalized medicine diagnostics.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Shanghai Biotecan pharmaceuticals Co.,Ltd
China · 3 relevant products
BioChain (Beijing) Science & Technology. Inc.
China · 2 relevant products
LifeOS Genomics Corporation
Taiwan · 2 relevant products
51 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →15 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 94 closest product alternatives
Shanghai Biotecan pharmaceuticals Co.,Ltd · China
Precision medicine diagnostic test for prenatal screening and maternal-fetal health assessment. Covers genetic and molecular markers relevant to obstetric and pediatric care.
BioChain (Beijing) Science & Technology. Inc. · China
Non-invasive prenatal testing panel for fetal genetic and chromosomal abnormality screening. This test supports optimal pregnancy outcomes through early detection of maternal and fetal health risks. The product is part of the company's maternal-fetal medicine offerings.
LifeOS Genomics Corporation · Taiwan
QLoci-based assay panel for non-invasive prenatal testing that identifies and quantitates fetal cell-free DNA (cfDNA) fragments. Provides genetic screening with minimal sample requirements and high sensitivity.
91 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products